Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2025-12-24 @ 6:55 PM
NCT ID:
NCT01597557
Eligibility Criteria:
Inclusion Criteria:
* Patient with new onset Atrial fibrillation less than 48 hours after onset undergoing electrical cardioversion.
* Patients with atrial fibrillation longer than 48 hours on warfarin with documented therapeutic INR levels \>2 for at least 3 weeks prior to the cardioversion, or been on dabigatran for 3 weeks, or a transesophageal echocardiogram on the day of the procedure that excludes intracardiac thrombi, undergoing electrical cardioversion.
Exclusion Criteria:
* Creatinine \>2.0 mg/dl
* Potassium level less than 3.5 mmol/dl
* TSH \< 0.5
* Magnesium levels \>3.0 mg/dl
* Urgent need for cardioversion (e.g., hemodynamic instability, unstable angina, pulmonary edema)
* Patients with recent (less than 6 weeks) acute myocardial infarction
* Patients post-cardiac surgery
* Pregnant women
* Patients who are being treated with antiarrhythmic drugs who have received less than five doses of the drug. For amiodarone, patients who have received less than three weeks prior to cardioversion are excluded.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01597557
Study Brief:
Protocol Section:
NCT01597557